← All stocks

Kymera Therapeutics, Inc.

KYMR Net selling
CIK 0001815442 #936 in the set updated 17 Sep 2026
Bought (12 mo)
$172.50M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$471.52M
$186.16M on a plan · $86.73M straight out of an exercise
Sold at will
$198.63M
42 of 264 sales
Net
−$299.02M
−$26.13M against sales at will

By person

14 insiders · 271 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Booth Bruce
Director
$217.75M (146) scheduled
−$217.75M
466,077
0.5605%
$54.80M
−81.5%
BVF PARTNERS L P/IL entity
Director
$173.67M (4)
−$173.67M
318,910
0.3835%
$37.49M
−80.5%
BAKER BROS. ADVISORS LP entity
Director
$172.50M (2)
+$172.50M
7,955,916
9.57%
$935.38M
+50.3%
Mainolfi Nello
Chief Executive Officer
$33.41M (20) scheduled
−$33.41M
666,568
0.8016%
$78.37M
+2.4%
Chadwick Jeremy G
Chief Operating Officer
$15.60M (29) scheduled
−$15.60M
44,018
0.0529%
$5.18M
−4.6%
Jacobs Bruce N.
Chief Financial Officer
$13.92M (16) scheduled
−$13.92M
244,883
0.2945%
$28.79M
+44.2%
Gollob Jared
Chief Medical Officer
$9.13M (18) scheduled
−$9.13M
117,134
0.1409%
$13.77M
+22.3%
Esposito Pamela
Director
$3.05M (12) scheduled
−$3.05M
1,000
0.0012%
$117.57K
Goodman Noah
Chief Business Officer
$2.22M (9) scheduled
−$2.22M
47,179
0.0567%
$5.55M
+10,282%
Ridloff Elena
Director
$1.29M (4) scheduled
−$1.29M
0
0.0000%
$0.00
Albers Jeffrey W.
Director
$744.77K (3) scheduled
−$744.77K
0
0.0000%
$0.00
Adams Brian
Chief Legal Officer
$744.30K (3)
−$744.30K
50,254
0.0604%
$5.91M
Chiniara Ellen
Chief Legal Officer
80,085
0.0963%
$9.42M
+38.2%
Rooney Terence
Chief Medical Officer
38,000
0.0457%
$4.47M
Insider
Date
Role
Action
Shares
Price
Amount
Jacobs Bruce N.
2 Jun 2026
Chief Financial Officer
Exercised, kept
12,653
$2.08
$26.32K
Esposito Pamela
19 May 2026
Director
Exercised, kept
1,000
$31.20
$31.20K
Jacobs Bruce N.
18 May 2026
Chief Financial Officer
Exercised, kept
15,000
$2.08
$31.20K
Mainolfi Nello
5 Jan 2026
Chief Executive Officer
Exercised, kept
3,118
$32.07
$99.99K
Mainolfi Nello
17 Dec 2025
Chief Executive Officer
Exercised, kept
2,595
$38.53
$99.99K
Showing 250 of 271 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 65
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 132
Sales straight out of an exercise 90
Sales at will 42
Transactions with no price 0
Shares from compensation/vesting 981,459
History held since 21 Aug 2020